{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T04:07:23Z","timestamp":1745640443945,"version":"3.40.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging Clinics of North America"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.mric.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:21:15Z","timestamp":1739535675000},"page":"271-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MR Imaging of Autoimmune Inflammatory and Demyelinating Myelopathies"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2132-6750","authenticated-orcid":false,"given":"\u00c0lex","family":"Rovira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7824-3796","authenticated-orcid":false,"given":"Estibaliz Saez","family":"de Gordoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-4767","authenticated-orcid":false,"given":"Cristina","family":"Auger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mric.2025.01.004_bib1","first-page":"1233","article-title":"Magnetic resonance imaging in immune-mediated myelopathies","volume":"267","author":"Wendebourg","year":"2020","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11910-020-01088-6","article-title":"Immune-mediated disorders affecting the spinal cord and the spine","volume":"21","author":"Perez Giraldo","year":"2021","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.mric.2025.01.004_bib3","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.mric.2025.01.004_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1148\/radiol.2231010707","article-title":"Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging","volume":"223","author":"Bot","year":"2002","journal-title":"Radiology"},{"issue":"Pt 4","key":"10.1016\/j.mric.2025.01.004_bib5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/brain\/121.4.687","article-title":"Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms","volume":"121","author":"Nijeholt","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.mric.2025.01.004_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(03)00504-0","article-title":"Spinal-cord MRI in multiple sclerosis","volume":"2","author":"Lycklama","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","article-title":"Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"18","author":"Ciccarelli","year":"2019","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.mric.2025.01.004_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.60.1.15","article-title":"MRI dynamics of brain and spinal cord in progressive multiple sclerosis","volume":"60","author":"Kidd","year":"1996","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mric.2025.01.004_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1212\/WNL.46.2.373","article-title":"Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis","volume":"46","author":"Thorpe","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2025.01.004_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1212\/01.wnl.0000341324.55937.d9","article-title":"Open-ring peripherally enhancing lesion of the cervical spine","volume":"72","author":"Pyle","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2025.01.004_bib12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneurol.2010.271","article-title":"Spinal cord ring enhancement in multiple sclerosis","volume":"67","author":"Klawiter","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib13","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A\u00a0serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.mric.2025.01.004_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.24582","article-title":"Discriminating long myelitis of neuromyelitis optica from sarcoidosis","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of neuromyelitis optica: a systematic review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2025.01.004_bib16","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jamaneurol.2021.3416","article-title":"Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review","volume":"78","author":"Amezcua","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncl.2023.06.009","article-title":"Updates in NMOSD and MOGAD diagnosis and treatment: a tale of two central nervous system autoimmune inflammatory disorders","volume":"42","author":"Cacciaguerra","year":"2024","journal-title":"Neurol Clin"},{"key":"10.1016\/j.mric.2025.01.004_bib18","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2025.01.004_bib21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/jnnp.2005.080390","article-title":"Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG","volume":"77","author":"Nakashima","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mric.2025.01.004_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1011579","article-title":"Myelitis features and outcomes in CNS demyelinating disorders: comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD","volume":"13","author":"Fadda","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1148\/rg.2018170141","article-title":"Neuromyelitis optica spectrum disorders: spectrum of MR imaging findings and their differential diagnosis","volume":"38","author":"Dutra","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.mric.2025.01.004_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101487","article-title":"The frequency of longitudinally extensive transverse myelitis in MS: a population-based study","volume":"37","author":"Asnafi","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.mric.2025.01.004_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1352458515591069","article-title":"Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging","volume":"22","author":"Pekcevik","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.mric.2025.01.004_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jns.2016.11.035","article-title":"The characteristics of spinal imaging in different types of demyelinating diseases","volume":"372","author":"Dumrikarnlert","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.mric.2025.01.004_bib27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2025.01.004_bib28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","article-title":"Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica","volume":"4","author":"Jarius","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib29","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/ene.14654","article-title":"Myelitis in inflammatory disorders associated with myelin oligodendrocyte glycoprotein antibody and aquaporin-4 antibody: a comparative study in Chinese Han patients","volume":"28","author":"ZhangBao","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1352458516687043","article-title":"Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders","volume":"23","author":"Huh","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.mric.2025.01.004_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgGpositive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrneurol.2018.14","article-title":"The current role of MRI in differentiating multiple sclerosis from its imaging mimics","volume":"14","author":"Geraldes","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.mric.2025.01.004_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/jnnp-2016-314738","article-title":"Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders","volume":"88","author":"Zalewski","year":"2017","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mric.2025.01.004_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458513495581","article-title":"\u201cBright spotty lesions\u201d on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis","volume":"20","author":"Yonezu","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.mric.2025.01.004_bib36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/13524585211060326","article-title":"Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD","volume":"28","author":"Hyun","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.mric.2025.01.004_bib37","first-page":"28","article-title":"Diagnostic value of bright spotty lesions on MRI after a first episode of acute myelopathy","volume":"48","author":"Rabaste","year":"2021","journal-title":"J\u00a0Neuroradiol"},{"key":"10.1016\/j.mric.2025.01.004_bib38","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000343","article-title":"Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder","volume":"4","author":"Asgari","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.mric.2025.01.004_bib39","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1212\/WNL.0b013e3182703ff7","article-title":"Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody","volume":"79","author":"Takai","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2025.01.004_bib40","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/01.wnl.0000183151.19351.82","article-title":"Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica","volume":"65","author":"Misu","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2025.01.004_bib41","first-page":"2396","article-title":"Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies","volume":"260","author":"Iorio","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1212\/CPJ.0000000000000104","article-title":"Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy","volume":"5","author":"Flanagan","year":"2015","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.mric.2025.01.004_bib43","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib44","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/1352458519845112","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","volume":"26","author":"de Mol","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.mric.2025.01.004_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12732","article-title":"Comparison of clinical outcomes of transverse myelitis among adults with myelin oligodendrocyte glycoprotein antibody vs aquaporin-4 antibody disease","volume":"2","author":"Mariano","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.mric.2025.01.004_bib46","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2025.01.004_bib47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mric.2025.01.004_bib48","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.mric.2025.01.004_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1210972","article-title":"Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"14","author":"Perez-Giraldo","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib50","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","article-title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib51","article-title":"Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies","volume":"20","author":"Sechi","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.mric.2025.01.004_bib52","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209303","article-title":"Radiologic lag and brain MRI lesion dynamics during attacks in MOG antibody-associated disease","volume":"102","author":"Cacciaguerra","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2025.01.004_bib53","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/1352458519849511","article-title":"Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: a retrospective multicentric study","volume":"26","author":"Ciron","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.mric.2025.01.004_bib54","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2214\/AJR.20.24061","article-title":"MOGAD: how it differs from and resembles other neuroinflammatory disorders","volume":"216","author":"Shahriari","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.mric.2025.01.004_bib55","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28871","article-title":"Comparison of spinal cord magnetic resonance imaging features among children with acquired demyelinating syndromes","volume":"4","author":"Fadda","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.mric.2025.01.004_bib56","first-page":"1052","volume":"30","author":"Sechi","year":"2024","journal-title":"NMOSD and MOGAD Continuum (Minneap Minn)"},{"key":"10.1016\/j.mric.2025.01.004_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103127","article-title":"Conus medullaris involvement in demyelinating disorders of the CNS: a comparative study","volume":"54","author":"Etemadifar","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.mric.2025.01.004_bib58","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2025.01.004_bib59","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib60","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/acn3.52001","article-title":"Peripheral nervous system manifestations of MOG antibody-associated disease","volume":"11","author":"Gupta","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib61","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000924","article-title":"Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders","volume":"8","author":"Rinaldi","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.mric.2025.01.004_bib62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jnnp-2023-331137","article-title":"Cerebral enhancement in MOG antibody-associated disease","volume":"95","author":"Elsbernd","year":"2023","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mric.2025.01.004_bib63","article-title":"Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS","author":"Banks","year":"2020","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.mric.2025.01.004_bib64","doi-asserted-by":"crossref","first-page":"e1097","DOI":"10.1212\/WNL.0000000000012467","article-title":"Comparison of MRI lesion evolution in different central nervous system demyelinating disorders","volume":"97","author":"Sechi","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2025.01.004_bib65","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.25957","article-title":"Silent new brain MRI lesions in children with MOG-antibody associated disease","volume":"89","author":"Fadda","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mric.2025.01.004_bib66","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37833","article-title":"Frequency of new silent MRI lesions in myelin oligodendrocyte glycoprotein antibody disease and aquaporin-4 antibody neuromyelitis optica spectrum disorder","volume":"4","author":"Camera","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.mric.2025.01.004_bib67","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0000000000201263","article-title":"Frequency of new or enlarging lesions on MRI outside of clinical attacks in patients with MOG-antibody-associated disease","volume":"99","author":"Syc-Mazurek","year":"2022","journal-title":"Neurology"}],"container-title":["Magnetic Resonance Imaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968925000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968925000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T14:17:16Z","timestamp":1745590636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064968925000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1064968925000042"],"URL":"https:\/\/doi.org\/10.1016\/j.mric.2025.01.004","relation":{},"ISSN":["1064-9689"],"issn-type":[{"type":"print","value":"1064-9689"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MR Imaging of Autoimmune Inflammatory and Demyelinating Myelopathies","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mric.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}